Back

Pharma

WEBINAR Airflow Visualisation (Smoke studies) & Cleanroom Compliance in Biopharma

  • 9th June 2026
  • Online | Cvent 11:50-17:10 CEST

This 4-session webinar series provides a comprehensive, practitioner-led exploration of cleanroom design, airflow visualisation, and qualification requirements under EU GMP Annex 1 (2022), ISO 14644, and FDA aseptic processing guidance. The programme spans cleanroom design fundamentals, smoke study methodology, HVAC engineering, and environmental monitoring strategy. Each session is designed to stand alone but together forms a complete learning journey — from foundational design principles through to inspection-ready qualification documentation.

Read more

Cleanroom design and airflow control sit at the very core of contamination prevention in biopharmaceutical manufacturing. As regulatory expectations intensify — most notably with the release of EU GMP Annex 1 (2022) — organisations are under mounting scrutiny to demonstrate that every Grade A and Grade B zone performs as intended, not just on paper, but in live, operational conditions.

This 4-session webinar series, From Smoke to Compliance, is designed to deliver a complete, practitioner-led journey through the engineering, regulatory, and qualification dimensions of cleanroom design. Drawing on the requirements of EU GMP Annex 1 (2022), ISO 14644-1/2, and FDA aseptic processing guidance, the programme equips professionals with the technical depth and regulatory confidence to design, qualify, and defend cleanroom environments at inspection.

Each session has been architected to deliver standalone value while collectively forming a complete learning pathway — from foundational design principles and airflow visualisation methodology, through HVAC engineering and environmental monitoring, to qualification strategies and inspection readiness.

The series is led by practitioners with hands-on experience in cleanroom design, smoke study execution, and regulatory inspection — ensuring that every module goes beyond theory and delivers tools and frameworks directly applicable in your organisation.

Cross-Series Outcomes:

  • Build a comprehensive regulatory framework map spanning EU GMP Annex 1 (2022), ISO 14644 and FDA aseptic processing guidance
  • Apply practical smoke study protocols and airflow visualisation methodologies that satisfy EMA and FDA inspection requirements
  • Develop a risk-based, inspection-ready cleanroom qualification and environmental monitoring programme adaptable across sterile manufacturing environments

Who Should Attend:

This series has been developed for professionals working in or intersecting with GMP-regulated sterile and aseptic manufacturing environments who are responsible for cleanroom design, qualification, environmental monitoring, or regulatory compliance. Whether your focus is engineering, quality, operations, or regulatory affairs, each session delivers directly applicable value.

  • Quality Assurance & Cleanroom Quality Managers

Understand what has changed under EU GMP Annex 1 (2022) and ISO 14644, translate new requirements into compliant cleanroom quality systems, and build audit-ready documentation for smoke studies and environmental monitoring programmes.

  • Regulatory Affairs Professionals

Gain clarity on how regulators are currently interpreting airflow visualisation and cleanroom qualification requirements globally, and understand the inspection expectations for smoke study documentation and HVAC qualification evidence.

  • Cleanroom & Facility Engineers

Apply Annex 1-aligned design principles to new-build and retrofit cleanroom projects — covering UDAF zone design, pressure differential strategies, AHU configurations, and HEPA filtration approaches that satisfy qualification requirements.

  • Validation & Qualification Specialists

Structure and execute IQ/OQ/PQ protocols for cleanroom and HVAC systems, manage re-qualification triggers, and build qualification packages that withstand regulatory scrutiny during inspections and submissions.

  • Environmental Monitoring Scientists & Microbiologists

Design and justify a risk-based environmental monitoring programme — viable and non-viable — that aligns with Annex 1 (2022) expectations for sampling locations, alert and action limits, and trend analysis.

  • Manufacturing & Operations Leaders

Understand the operational implications of cleanroom classification, airflow management, and smoke study requirements — including personnel simulation, intervention protocols, and contamination risk management on the shop floor.

  • Senior Leaders & Heads of Quality / Manufacturing

Build strategic oversight across the cleanroom design and compliance landscape to make informed decisions on facility investment, qualification strategy, and inspection readiness.

This series is equally valuable for professionals at pharmaceutical manufacturers, biologic and ATMP developers, CDMOs, CROs, and engineering consultancies operating under EU GMP and FDA regulatory frameworks.

KEY PRACTICAL LEARNING POINTS

  • Explain cleanroom classification under ISO 14644-1/2 and EU GMP Grades A–D and map to FDA expectations
  • Describe the key design requirements introduced by EU GMP Annex 1 (2022) for aseptic manufacturing zones
  • Apply unidirectional airflow (UDAF) design principles and pressure cascade strategies in cleanroom layout
  • Design, execute, and document smoke studies that meet EMA, FDA, and PIC/S regulatory expectations
  • Understand acceptance criteria for airflow visualisation: first-pass airflow, turbulence at critical surfaces, and dynamic vs. static conditions
  • Configure HVAC systems for compliant Grade A/B/C/D environments — air change rates, HEPA filtration, and pressure differentials
  • Build a viable and non-viable environmental monitoring programme with defensible alert and action limits
  • Navigate IQ/OQ/PQ qualification protocols for cleanroom and HVAC systems and manage re-qualification triggers
  • Identify common inspection deficiencies in airflow visualisation and cleanroom qualification — and how to avoid them

Volkmar Balzer, DE

Managing Director, Contamination Control Instruments

CCI vK GmbH & Co. KG

Johannes Rauschnabel, DE

Senior Director Pharma Excellence

Syntegon Technology GmbH 

Johannes Rauschnabel is a studied chemist with a PhD from Tuebingen University, Germany.
Johannes has more than 25 years of experience in Pharma packaging industry with roles in r&d, in product management for barrier systems, as head of process development, as a Chief Pharma Expert, as a Director Advanced Technology Development and Innovation at Syntegon Technology GmbH (former Bosch Packaging). Since April 2025 he is leading a new function Pharma Excellence in the same company – focussed on sterile fill/finish equipment.

Johannes holds a variety of patents, has published many scientific papers and is a frequent speaker at Pharma events. He is heading ISPE DACH’s Community of Practice on Aseptic Processing and is a vice president of Packaging Valley Germany.

Varadharaj Vijayakumar, DE

Associate Director

Terumo Pharmaceuticals Services GmbH

 

Varadharaj (Varad) Vijayakumar is an internationally experienced pharmaceutical professional specializing in aseptic processing, sterile manufacturing, and contamination control. He is the author of the best-selling book Mastering Aseptic Processing, widely recognized by pharmaceutical professionals for its practical and regulatory-driven approach to sterile manufacturing.

With more than 16 years of experience in pharmaceutical and biopharmaceutical technical operations, Varad has deep expertise in sterility assurance, aseptic operations, contamination control strategies (CCS), validation, lyophilization, isolator technology, and VHP decontamination. He is known for applying science- and risk-based approaches to resolve complex GMP and regulatory challenges in high-risk sterile manufacturing environments.

Varad currently serves as Associate Director – Aseptic Processing at Terumo Pharmaceutical Solutions GmbH and is Co-founder of Quantum Bio-Consulting. During his career he has held senior technical roles at organizations including WuXi Biologics, Pfizer, Franz Ziel GmbH, Dr. Reddy’s Laboratories, Emcure Pharmaceuticals, Biocon Biologics, and Caplin Steriles.

An active member of ISPE and PDA, Varad is a global speaker and trainer who delivers programs on aseptic processing, qualification, validation, and contamination risk management. He has trained pharmaceutical teams across Europe, the United States, the United Kingdom, Mexico, Thailand, India, and Germany. 

Morgan Polen, US

Cleanroom Contamination Control Expert

Microrite, Inc.

Morgan Polen is a subject matter expert in the field of contamination control and airflow visualization in cleanrooms. Morgan has over 35 Years of experience working in cleanrooms and controlled environments in many different industries.

Morgan’s Technical Leadership:

  • Internationally recognized educator in the field of contamination control
  • Member of U.S. Technical Advisory Group to ISO Technical Committee 209
  • Member of ASTM Subcommittee E55.06 Working Group “Guide for Critical Airflow Visualization”
  • Board member of the Institute of Environmental Sciences and Technology (IEST)

Morgan has been instrumental in drafting and editing international cleanroom standards, contamination control guidelines and best practices. He has extensive experience working on cleanroom projects all over the word. Morgan is a valuable resource in addressing contamination control in critical environments for the electronics, aerospace and healthcare industries.

As a key member of Microrite’s Expert Contamination Control team, Morgan is instrumental in development of proactive contamination control strategies through pragmatic risk assessment, particle testing and airflow visualization. Morgan’s broad experience troubleshooting contamination issues has helped companies identify and remediate contamination related problems such as:

  • Identify sources of particulate, microbial, fungal, molecular, and electrostatic contamination
  • Assist in FDA 483 observations or warning letter remediation's

Volkmar Balzer, DE

Managing Director, Contamination Control Instruments

CCI vK GmbH & Co. KG

Johannes Rauschnabel, DE

Senior Director Pharma Excellence

Syntegon Technology GmbH 

Varadharaj Vijayakumar, DE

Associate Director

Terumo Pharmaceuticals Services GmbH

 

Morgan Polen, US

Cleanroom Contamination Control Expert

Microrite, Inc.

RECORDINGS

Request Airflow Visualisation (Smoke studies) & Cleanroom Compliance in Biopharma Online Webinar RECORDINGS and find out the latest topics and ideas that were shared.

Request

Please fill in your e-mail address below, and we will process your request shortly.

Please note that some of our emails may be marked as spam due to your company’s security settings. To ensure we stay in touch, you can also connect directly with Emma at [email protected]